Lung Diseases 
Welcome,         Profile    Billing    Logout  

5 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lung Diseases
NCT01784562 / 2012-002104-40: Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

No Longer Available
3
Japan, US, Canada, Europe, RoW
Adempas (Riociguat, BAY63-2521)
Bayer
Hypertension, Pulmonary
 
 
AVAPS-AE COPD, NCT01611870: AVAPS-AE Algorithm in Chronic Obstructive Pulmonary Disease (COPD)Patients

 
N/A
20
Europe
AVAPS-AE, AVAPS-AE mode of ventilator therapy
Philips Respironics
Chronic Obstructive Pulmonary Disease
12/12
12/12
NCT02230982: Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis

No Longer Available
N/A
RoW
nintedanib
Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis
 
 
CanCOLD, NCT00920348: The Canadian Cohort Obstructive Lung Disease

Active, not recruiting
N/A
1500
Canada
McGill University Health Centre/Research Institute of the McGill University Health Centre, Canadian Institutes of Health Research (CIHR), GlaxoSmithKline, AstraZeneca, Pfizer, Boehringer Ingelheim, Novartis, Takeda, Merck Sharp & Dohme LLC, Almirall, SAS
COPD, Chronic Obstructive Pulmonary Disease
12/22
12/22
NCT01632475: Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia

Active, not recruiting
N/A
9
RoW
Pneumostem®, Human umbilical cord blood-derived mesenchymal stem cells
Samsung Medical Center, Medipost Co Ltd.
Bronchopulmonary Dysplasia
09/25
09/26

Download Options